244 studies found for:    Open Studies | "Hepatitis B"
Show Display Options
Rank Status Study
1 Recruiting Tenofovir DF With or Without Peginterferon for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Negative;   Chronic Hepatitis B e Antigen Positive
Intervention: Drug: Peginterferon and Tenofovir
2 Recruiting Observational Study of Persons With Hepatitis B Virus Infection in North America
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention:
3 Recruiting Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention:
4 Recruiting Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Condition: Chronic Hepatitis B
Interventions: Drug: tenofovir disoproxil fumarate 300mg per day;   Drug: Placebo
5 Not yet recruiting Emtricitabine for Naive Chinese Chronic Hepatitis B Patients
Condition: Hepatitis B, Chronic
Intervention: Drug: Emtricitabine
6 Not yet recruiting Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients
Condition: Hepatitis B, Chronic
Intervention: Drug: Emtricitabine
7 Not yet recruiting Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B Patients
Conditions: Hepatitis B, Chronic;   Pregnancy
Intervention: Drug: Emtricitabine
8 Recruiting Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection
Conditions: Hepatitis B, Chronic;   Liver Fibrosis
Intervention: Drug: Treatment with entecavir(Baraclude®)
9 Not yet recruiting Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy
Conditions: Lymphoma;   Chronic Hepatitis B
Intervention:
10 Unknown  Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir and peginterferon (Pegasys) (52 weeks);   Drug: Peginterferon (Pegasys) (96 weeks);   Drug: Peginterferon (Pegasys) (48 weeks)
11 Unknown  Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir and peginterferon alfa-2a;   Drug: Placebo and peginterferon
12 Unknown  Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults
Condition: Hepatitis B
Intervention:
13 Unknown  A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B
Conditions: Hepatitis B, Chronic;   Liver Diseases;   Virus Diseases;   Hepatitis;   Diffuse Hepatic Disease
Intervention: Device: Liquid Acupuncture (Herb Acupoint Injection)
14 Unknown  Prednisolone Priming Study in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Prednisolone;   Drug: Placebo priming
15 Recruiting Hepatitis B Research Network Pediatric Cohort Study (HBRN)
Condition: Hepatitis B
Intervention:
16 Unknown  Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)
Conditions: Liver Cirrhosis;   Chronic Hepatitis B
Intervention: Drug: telbivudine
17 Unknown  Adolescents' Response to Hepatitis B Vaccine Booster Dose
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
18 Recruiting Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: NVR 3-778;   Drug: Placebo for NVR 3-778;   Drug: Pegasys
19 Recruiting Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention:
20 Recruiting Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy
Condition: Chronic Hepatitis B
Interventions: Drug: peg-interferon alpha 2b, 1.5mcg/kg s/c given weekly;   Drug: Nucleos(t)ide analogue therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years